Featured Research

from universities, journals, and other organizations

Combating Urinary Schistosomiasis: Both Metrifonate And Praziquantel Can Be Used

Date:
July 15, 2008
Source:
Wiley-Blackwell
Summary:
In 2000 the World Health Organization stopped recommending metrifonate for treating urinary schistosomiasis because the drug did not appear to be as effective as the treatment of choice, praziquantel. Now a systematic review published in the latest edition of The Cochrane Library indicates that both metrifonate and praziquantel are effective at treating the infection.

In 2000 the World Health Organization (WHO) stopped recommending metrifonate for treating urinary schistosomiasis because the drug did not appear to be as effective as the treatment of choice, praziquantel. Now a systematic review published in the latest edition of The Cochrane Library indicates that both metrifonate and praziquantel are effective at treating the infection.

The team of researchers who carried out this study suggest that metrifonate may be a valid addition to the current one-drug strategy against urinary schistosomiasis.

These findings were reached after considering the data in 24 trials that together involved 6,315 participants.

Urinary schistosomiasis occurs when a tiny worm, a blood fluke (Schistosoma haematobium), penetrates a person's skin while walking or bathing in fresh water contaminated with snails that contain the worm. The fluke lays eggs in the body, and these eggs cause tissue damage that leads to blood in urine and pain on passing urine. If left untreated they can cause serious disease including kidney failure. Estimates indicate that more than 100 million people in African and Eastern Mediterranean regions are infected by the flukes, resulting in considerable social and economic hardships.

Praziquantel requires only one dose and is operationally more convenient, while metrifonate requires three at 14-day intervals. This could be a strong reason for stopping metrifonate use, especially in rural community-based treatment programmes, where it is difficult to give multiple doses. However, the researchers believe that it would be prudent to have more than one drug in use in order to minimise the chance of the organism developing resistance against the only drug, praziquantel.

"Relying only on praziquantel for treating schistosomiasis is a risky strategy as it could encourage the development of drug resistance," says lead researcher Anthony Danso-Appiah, who works at the Liverpool School of Tropical Medicine, Liverpool, UK.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley-Blackwell. "Combating Urinary Schistosomiasis: Both Metrifonate And Praziquantel Can Be Used." ScienceDaily. ScienceDaily, 15 July 2008. <www.sciencedaily.com/releases/2008/07/080715204826.htm>.
Wiley-Blackwell. (2008, July 15). Combating Urinary Schistosomiasis: Both Metrifonate And Praziquantel Can Be Used. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2008/07/080715204826.htm
Wiley-Blackwell. "Combating Urinary Schistosomiasis: Both Metrifonate And Praziquantel Can Be Used." ScienceDaily. www.sciencedaily.com/releases/2008/07/080715204826.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins